Lachman has been providing
both onsite and remote
support to our clients
for many years.

Review Support Offerings
The Lachman Difference

The most efficient services.
The most qualified professionals.

Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA consultants and industry experts has offered compliance, regulatory affairs, and science & technology services to clients around the world.

Learn More About Us

Stay in the know

Sign up today for the Lachman Consultants blog.

Get the latest news on industry compliance, regulatory affairs, technical services, and a whole lot more.

    Lachman Practice Groups

    Three Practices
    Executing One Vision

    Lachman Consultants maintains three practice groups: Compliance, Regulatory Affairs, and Science and Technology. Each practice offers industry-leading experience and expertise in its area of focus.

    Lachman OnCall Logo

    Get the answers and guidance to your most pressing questions faster than ever before.

    Now you can speak to one of our Subject Matter Experts and get the answers you need quickly on the many pressing issues arising in the life science areas that Lachman Consultants serves on a day to day basis. Whether it’s something you need to know about compliance, or a complex scientific or technical issue, Lachman OnCall™️ can provide you the timely information you require as needs arise and unforeseen questions occur.

    Learn More About Lachman OnCall

    OnCall Image

    Recent Posts

    The Lachman Consultants Blog

    The latest on industry compliance, regulatory affairs, technical services, and a whole lot more.

    COVID-19 Variant Mutations Could Impact Test Results

    Yesterday, the FDA published a document (here) detailing potential imp...
    Read More

    Just in Case You Couldn’t Attend – The Lachman Learning Experience Data Integrity Webinar

    Data integrity is an ever-increasing concern in the life sciences as e...
    Read More

    New Dissolution Method for Long-Acting Injectable Suspensions May Provide Better Data

    FDA and industry have long wrestled with appropriate dissolution metho...
    Read More

    November 2021 Unofficial Approval Actions for OGD – And Yes, It Looks Like Thanksgiving

    Well, OGD is back over the 70 mark for total number of approval action...
    Read More

    FY 2022 Research Priorities for Generic Drugs Outlined in FDA Document

    FDA has released its revised outline of specific generic drug research...
    Read More
    Grandfather speaking during Christmas dinner, family members cla

    Happy Thanksgiving from Your Friends at Lachman Consultants

    Here we are, another Thanksgiving almost in the books, and reading the...
    Read More
    Contact Us Today